Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Cornelia van Duijn

Professor Cornelia van Duijn

Cornelia van Duijn

Professor of Epidemiology

Cornelia van Duijn is Professor of Epidemiology at Oxford Population Health and Fellow of St Cross College, Oxford, and co-leads the HDR UK Oxford Region.

Her research within the Oxford Big Data Institute focuses on large-scale –omics studies of neurodegenerative disorders including Alzheimer, Parkinson and Creutzfeldt–Jakob disease and ophthalmological disorders including glaucoma, age-related macular degeneration and myopia.

She further studies systemic vascular, endocrine and gastrointestinal pathology that is relevant for brain and ocular function. Her current research portfolio includes cross-omics research integrating (epi)genetic, transcriptomic, proteomic, metabolomic and microbiome data of epidemiological cohorts with state of the art brain imaging and cellular model systems.

Over the  years, Cornelia has been a leading figure in several international consortia including ENGAGE (European Network for Genetic and Genomic Epidemiology), CHARGE (Cohorts for Heart & Aging  Research in Genome Epidemiology), IGAP (International Genetics of Alzheimer Disease Project, ADSP  (Alzheimer Disease Sequencing Project) and IGGC (International Genetics of Glaucoma Consortium).

At present, she is the leader of two major consortia: the Horizon2020 CoSTREAM consortium aiming to understand the link between stroke and Alzheimer disease and the MEMORABEL Gut-Brain consortium aiming to unravel the role of the gut microbiome in Alzheimer disease and brain pathology.

She further leads the human proteomics and metabolomics discovery research in the Innovative Medicine Initiative (IMI) ADAPTED programme, which aims to identify new Alzheimer medicines through understanding the function of the APOE gene. Cornelia is a member of the Royal Netherlands Academy of Arts and Sciences (KNAW) and the Netherlands Council for Medical Sciences (RMW).

Cornelia studied Human Nutrition and Mathematical Statistics at the Agricultural University of Wageningen and Genetics and Epidemiology at the Erasmus University Medical School.